Global IV Flush Syringe market will reach 440 million US$ by the end of 2025 QYRESEARCH FOCUS ON MARKET SURVEY AND RESEARCH
www.qyresearch.com
CONTACT
Beijing Hengzhou Bozhi International Information Consulting Web: www.qyresearch.com TEL:+86-13660489419, Office:+86-2022093278 Media: press@qyresearch.com
Marketing: sales@qyresearchglobal.com Facebook: @QYResearchOfficial Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智
QYResearch • Health care professionals use IV flush syringes to clear out patients’ catheters and intravenous lines to ensure the tubes are sterile. Nurse Assist, a Texas-based medical device manufacturer, recalled all of its Normal Saline IV Flush Syringes in 2016 after the devices spread a bacterial infection. Patients became sick and some died. How the syringes became contaminated with the bacteria Burkholderia cepacia remains unknown.
QYR
• In the last several years, global market of IV Flush Syringe developed rapidly, with an average growth rate of 6.18%. In 2017, global revenue of IV Flush Syringe is nearly 274 M USD; the actual production is about 426 million units. • The classification of IV Flush Syringe includes Saline IV Flush Syringe and Heparin IV Flush Syringe, and the proportion of Saline IV Flush Syringe in 2017 is about 72.5%, and the proportion is decreasing trend from 2012 to 2017.
QYR
IV Flush Syringe is widely sales for Hospital, Clinic and Others Institutions. The most proportion of IV Flush Syringe is sales in Hospital, and the consumption proportion is about 53% in 2017. The global IV Flush Syringe market is valued at 270 million US$ in 2017 and will reach 440 million US$ by the end of 2025, growing at a CAGR of 6.2% during 2018-2025.
Click to view the full report: https://www.qyresearch.com/index/detail/387112/globaliv-flush-syringe-sales-market